These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 18986288)
1. Spectrum of microbial etiology of community-acquired pneumonia in hospitalized patients: implications for selection of the population for enrollment in clinical trials. Mandell LA Clin Infect Dis; 2008 Dec; 47 Suppl 3():S189-92. PubMed ID: 18986288 [TBL] [Abstract][Full Text] [Related]
2. The role of new therapies for severe community-acquired pneumonia. Restrepo MI; Anzueto A Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331 [TBL] [Abstract][Full Text] [Related]
3. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay. Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876 [TBL] [Abstract][Full Text] [Related]
4. Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy. Niven DJ; Laupland KB Expert Rev Anti Infect Ther; 2009 Feb; 7(1):69-81. PubMed ID: 19622058 [TBL] [Abstract][Full Text] [Related]
5. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Ramirez J; Aliberti S; Mirsaeidi M; Peyrani P; Filardo G; Amir A; Moffett B; Gordon J; Blasi F; Bordon J Clin Infect Dis; 2008 Jul; 47(2):182-7. PubMed ID: 18533841 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic testing to establish a microbial cause is helpful in the management of community-acquired pneumonia. Skerrett SJ Semin Respir Infect; 1997 Dec; 12(4):308-21. PubMed ID: 9436958 [TBL] [Abstract][Full Text] [Related]
7. Is it possible to blind a trial for community-acquired pneumonia? Boucher HW Clin Infect Dis; 2008 Dec; 47 Suppl 3():S210-5. PubMed ID: 18986292 [TBL] [Abstract][Full Text] [Related]
8. Unique considerations in the evaluation of antibacterials in clinical trials for pediatric community-acquired pneumonia. Bradley JS; McCracken GH Clin Infect Dis; 2008 Dec; 47 Suppl 3():S241-8. PubMed ID: 18986297 [TBL] [Abstract][Full Text] [Related]
9. Lower respiratory tract infection and pneumonia in the community. Macfarlane J Semin Respir Infect; 1999 Jun; 14(2):151-62. PubMed ID: 10391409 [TBL] [Abstract][Full Text] [Related]
10. Placebo-controlled trials of treatments for community-acquired pneumonia: review of the literature and discussion of feasibility and potential value. Murphy TF Clin Infect Dis; 2008 Dec; 47 Suppl 3():S145-9. PubMed ID: 18986281 [TBL] [Abstract][Full Text] [Related]
11. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project. Bratzler DW; Ma A; Nsa W Clin Infect Dis; 2008 Dec; 47 Suppl 3():S193-201. PubMed ID: 18986289 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin. Bergallo C; Jasovich A; Teglia O; Oliva ME; Lentnek A; de Wouters L; Zlocowski JC; Dukart G; Cooper A; Mallick R; Diagn Microbiol Infect Dis; 2009 Jan; 63(1):52-61. PubMed ID: 18990531 [TBL] [Abstract][Full Text] [Related]
14. Management of community-acquired pneumonia by trained family general practitioners. Potena A; Simoni M; Cellini M; Cartabellotta A; Ballerin L; Piattella M; Putinati S Int J Tuberc Lung Dis; 2008 Jan; 12(1):19-25. PubMed ID: 18173872 [TBL] [Abstract][Full Text] [Related]
15. Worldwide perspective of the quality of care provided to hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study. Ramírez JA; Semin Respir Crit Care Med; 2005 Dec; 26(6):543-52. PubMed ID: 16388426 [TBL] [Abstract][Full Text] [Related]
16. [Neumonía acquired in the community. Practical guide elaborated by a committee intersocieties]. Luna CM; Calmaggi A; Caberloto O; Gentile J; Valentini R; Ciruzzi J; Clara L; Rizzo O; Lasdica S; Blumenfeld M; Benchetrit G; Famiglietti A; Apezteguia C; Monteverde A; Medicina (B Aires); 2003; 63(4):319-43. PubMed ID: 14518147 [TBL] [Abstract][Full Text] [Related]
18. An open-label, randomized comparison of levofloxacin and amoxicillin/clavulanate plus clarithromycin for the treatment of hospitalized patients with community-acquired pneumonia. Lin TY; Lin SM; Chen HC; Wang CJ; Wang YM; Chang ML; Wang CH; Liu CY; Lin HC; Yu CT; Hsieh LL; Kuo HP; Huang CD Chang Gung Med J; 2007; 30(4):321-32. PubMed ID: 17939262 [TBL] [Abstract][Full Text] [Related]
19. Impact of guidelines on outcome: the evidence. Martínez R; Reyes S; Lorenzo MJ; Menéndez R Semin Respir Crit Care Med; 2009 Apr; 30(2):172-8. PubMed ID: 19296417 [TBL] [Abstract][Full Text] [Related]
20. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA; Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]